Parkinson Research Consortium
Our team
The Parkinson’s Research Consortium (PRC) is composed of a select group of scientists from the Ottawa Hospital Research Institute (OHRI) and the uOttawa Brain and Mind Research Institute with diverse scientific talents and expertise in genetics, molecular biology, neuroscience and patient care. It continues to grow in productivity, personnel and resources to help find a cure for Parkinson's disease.
Team leaders
David Grimes
Replace with David Grimes
Michael Schlossmacher
Senior Scientist, NeuroscienceResearchers
Paul Albert
Senior Scientist, Neuroscience
Steffany Bennett
Lipid biochemist, cell biologist, and systems neuroscientist studying neurodegeneration and neuroregeneration
Dennis Bulman
Geneticist, an expert at the identification of human disease genes
Tuan Bui
Research program in understanding how the nervous system controls movement, in particular, through the activity of the spinal cord
Simon Chen
Expert in neural circuits and behavior
Antonio Colavita
Senior Scientist, Neuroscience
Patrick Davidson
Cognitive neuroscience of human memory, executive functions, and emotion. Normal aging and age-related disorders (such as Alzheimer's and Parkinson's diseases)
Marc Ekker
internationally renowned developmental biologist who uses zebra fish as a model to study cell death mechanisms
Derek Gibbings
Expert in mechanisms of RNA processing and microRNAs
Shawn Hayley
An expert in neuroinflammatory mechanisms of neurodegeneration and links between environmental stressors and Parkinson's disease
Matthew Holahan
Expert in multiple memory systems, Alzheimer’s, axonal growth, neural development
Diane Lagace
Expert in performing behavioural phenotyping for the preclinical animal models
Lori Malva Della
Neuropsychologist
Tiago Mestre
Neurologist, specializing in Parkinson's disease and clinical research
Julie Nantel
Her research focuses on the development of novel tools to explain the mechanisms involved in freezing of gait in people with Parkinson’s disease
John Ngsee
Affiliate Investigator, Neuroscience
Robin Parks
Senior Scientist, Regenerative Medicine
Maxime Rousseaux
Expert in understanding the molecular mechanisms that underlie the pathogenesis of neurodegenerative diseases such as Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS)
Natalina Salmaso
Expert in Neurogenesis neuroplasticity, stressors, brain injury and cognitive delay
Adam Sachs
Associate Scientist, Neuroscience
Ruth Slack
Expert in stem cell biology and neuronal death
Mario Tiberi
Senior Scientist, Neuroscience
François Tremblay
Expert in Psychophysics of tactile sensations, neurophysiological aspects of human aging and sensori-motor integration in health and disease
Vance Trudeau
Expert in biology
Lisa Walker
Clinician Investigator, Neuroscience
John Woulfe
Associate Scientist, Neuroscience
It is crucial that we continue to advance this work.
“In some way, all of the Board members of the PRC have been impacted by Parkinson’s disease. In my case, my much-loved mother passed away after a long battle with the disease in 2013. We may be many years away from a cure, but I know that the funding we provide helps initiate important therapies that allow those with Parkinson’s to live full active lives.
It is extraordinary the research that is being carried out by the scientific and clinicians working with the grants that are being provided. It is crucial that we continue to advance this work.”
David Cork, FCSI
Senior Wealth Advisor, Vice President ScotiaMcLeod
Chair, Parkinson Research Consortium Advisory Board
Advisory Board of Directors
David Cork, Chair
Mara Arno
Jane Batten
Pat Evans
Colleen Ford
Andrew Frank
Rob Gibson
David Grimes, MD
(Co-Director)
Shelby Hayter
Christina Lewis
David Lewis, PhD
Sharon Martin
Tiago Mestre, MD
Natalina Salmaso, PhD
Michael Schlossmacher, MD
(Co-Director)
Ruth Slack, PhD
Karalee Bowles
Program Manager
Natasha Hollywood